Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Feb 5, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gritstone Bio, Inc.
| 105K |
—
|
—
| +13.22% | 899.35K |
Feb 1
| |||||||
Adaptimmune Therapeutics Plc
|
0
|
—
|
—
|
—
|
0
|
Jul 5
| |||||||
Adaptimmune Therapeutics Plc
|
0
|
—
|
—
|
—
|
0
|
Jul 3
| |||||||
Adaptimmune Therapeutics Plc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Tcr2 Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 1
| |||||||
Gritstone Bio, Inc.
| 738.55K |
—
|
—
| +624.83% | 856.75K |
Feb 2
| |||||||
Tcr2 Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 15
| |||||||
Sierra Oncology, Inc.
| -1.65K |
$55.00 | -$90,750.00 | -100.00% |
0
|
Jul 1
| |||||||
Gritstone Bio, Inc.
| 70K |
—
|
—
| +145.23% | 118.2K |
Jan 31
| |||||||
Tcr2 Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 9
| |||||||
Gritstone Bio, Inc.
| 48.2K |
—
|
—
|
∞
| 48.2K |
Jan 7
| |||||||
Epizyme, Inc.
| 8.06K |
—
|
—
| +64.48% | 20.56K |
Jun 11
| |||||||
Sierra Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Gritstone Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 8
| |||||||
Tcr2 Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 10
| |||||||
Sierra Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 9
| |||||||
Epizyme, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 29
| |||||||
Epizyme, Inc.
| 12.5K |
$9.33 | $116,625.00 |
∞
| 12.5K |
Mar 16
| |||||||
Gritstone Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 25
| |||||||
Tcr2 Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 19
| |||||||
Sierra Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 11
| |||||||
Epizyme, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 31
| |||||||
Tcr2 Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Apr 11
| |||||||
Gritstone Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 13
| |||||||
Tcr2 Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Sierra Oncology, Inc.
| 66K |
$1.64 | $108,240.00 |
∞
| 66K |
Dec 10
| |||||||
Gritstone Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Sierra Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 12
| |||||||
Epizyme, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 18
| |||||||
Sierra Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 10
| |||||||
Sierra Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Epizyme, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 22
| |||||||
Epizyme, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 19
| |||||||
Epizyme, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 8
| |||||||
Clovis Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 2
| |||||||
Clovis Oncology, Inc.
| -80.00K |
$65.87 | -$5,269,895.80 | -43.98% | 101.92K |
Jan 15 - Jan 16
|
Scheduled
| ||||||
Clovis Oncology, Inc.
| -80.00K |
$65.64 | -$5,251,292.52 | -43.98% | 101.92K |
Jan 15 - Jan 16
|
Scheduled
| ||||||
Epizyme, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 9
| |||||||
Epizyme, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Clovis Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 10
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.